Published On: Wed, Oct 19th, 2016

New Analyst Ratings On Liberator Medical Holdings, Inc. (LBMH)


Recently stock market analysts have updated their consensus ratings on shares of Liberator Medical Holdings, Inc. (LBMH).

Most recent broker ratings

10/29/2015 – Singular Research began new coverage on Liberator Medical Holdings, Inc. giving the company a “buy” rating. They now have a USD 3.6 price target on the stock.

08/28/2014 – Sidoti began new coverage on Liberator Medical Holdings, Inc. giving the company a “buy” rating.

01/06/2014 – Dawson James began new coverage on Liberator Medical Holdings, Inc. giving the company a “buy” rating. They now have a USD 8 price target on the stock.

Liberator Medical Holdings, Inc. has a 50 day moving average of 3.34 and a 200 day moving average of 2.72.It has a 52-week low of 1.96 and a 52-week high of 3.90.

The share price of the company (LBMH) was up +0.00% during the last trading session, with a high of 0.00 and the volume of Liberator Medical Holdings, Inc. shares traded was 0.

Liberator Medical Holdings, Inc. is a direct-to-consumer provider of medical supplies, primarily to Medicare-eligible seniors. The Company’s segment includes Mail Order Supplies. The Company markets its products to individuals with chronic illnesses who require continuous access to medical devices and supplies. It is a quasi-medical distributor providing home healthcare services. The Company distributes products that are classified as durable medical equipment (DME). It offers urological catheters, ostomy supplies, mastectomy fashions and diabetic supplies. It offers female intermittent catheters, indwelling female catheters and external catheters. It offers ostomy supplies, including colostomy, ileostomy and urostomy supplies. Its diabetes testing supplies include glucose meters, glucose test strips, control solution and lancets, offering diabetes testing supplies from the diabetes supply manufacturers. The Company offers mastectomy bras and mastectomy breast forms.